Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia

Psychiatric Genetics

Volumn 23, Issue 5, 2013, Pages 183-187

  Kordi Tamandani, D M ^a   Sahranavard, Roya ^a   Torkamanzehi, Adam ^a  

^a UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; GENOMIC DNA; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DNA METHYLATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SEQUENCE ANALYSIS;

CASE-CONTROL STUDIES; DNA METHYLATION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, DOPAMINE; RISK FACTORS; SCHIZOPHRENIA;

EID: 84883655674     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328363d6e1     Document Type: Article

References (21)

1. Abdolmaleky HM, Smith CL, Faraone S.V., Shafa R., Stone W, Glatt SJ, Tsuang M.T. (2004). Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet 127B:51-59. (Pubitemid 38542313)
2. Abdolmaleky HM, Thiagalingam S, Wilcox M. (2005). Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope. Am J Pharmacogenomics 5:149-160. (Pubitemid 40994274)
3. Cosentino M, Rasini E, Colombo C., Marino F, Blandini F, Ferrari M., et al. (2004). Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med 36:1233-1240. (Pubitemid 38526317)
4. Ferrari M, Cosentino M, Marino F., Bombelli R, Rasini E, Lecchini S., Frigo G. (2004). Dopaminergic D1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes. Biochem Pharmacol 67:865-873. (Pubitemid 38201632)
5. Glatt SJ, Faraone SV, Tsuang M.T. (2003). Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 8:911-915. (Pubitemid 37421697)
6. Ilani T, Ben-Shachar D, Strous R.D., Mazor M., Sheinkman A, Kotler M, Fuchs S. (2001). A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Natl Acad Sci USA 98:625-628. (Pubitemid 32105093)
7. Kordi-Tamandani D.M., Moazeni-Roodi A-K, Rigi-Ladiz M-A, Hashemi M, Birjandian E, Torkamanzehi A (2010). Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer. Arch Oral Biol 55:809-814.
8. Kordi-Tamandani D.M., Hashemi M, Sharifi N., Kaykhaei MA, Torkamanzehi A. (2012). Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Mol Biol Rep 39:937-943.
9. Kwak YT, Koo MS, Choi C.H., Sunwoo I. (2001). Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med Genet 2:3.
10. Okubo Y, Suhara T, Suzuki K., Kobayashi K, Inoue O, Terasaki O., et al. (1997). Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385:634-636.
11. Ostadali MR, Ahangari G, Eslami M.B., Razavi A., Zarrindast MR, Ahmadkhaniha HR, Boulhari J. (2004). The detection of dopamine gene receptors (DRD1-DRD5) expression on human peripheral blood lymphocytes by real time PCR. Iran J Allergy Asthma Immunol 3:169-174.
12. Petronis A (2000). The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology 23:1-12. (Pubitemid 30408307)
13. Roszman TL, Brooks W.H. (1985). Neural modulation of immune function. J Neuroimmunol 10:59-69. (Pubitemid 16224062)
14. Sadock BJ, Sadock VA, Ruiz P, Kaplan H.I. (2009). Kaplan & Sadock's comprehensive textbook of psychiatry. 9th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins 2009; p 2 v. (lix, 4520, I-138).
15. Santambrogio L, Lipartiti M, Bruni A., Dal Toso R (1993). Dopamine receptors on human T-and B-lymphocytes. J Neuroimmunol 45:113-119.
16. Schultz SH, North SW, Shields C.G. (2007). Schizophrenia: a review. Am Fam Physician 75:1821-1829. (Pubitemid 46954070)
17. Sedlackova L, Nguyen TT, Zlacka D, Sosna A., Hromadnikova I. (2009). Cell surface and relative mRNA expression of heat shock protein 70 in human synovial cells. Autoimmunity 42:17-24.
18. Seeman P, Niznik H.B. (1990). Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J 4:2737-2744.
19. Sharma A, Kramer ML, Wick P.F., Liu D., Chari S, Shim S, et al (1999). D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia. Mol Psychiatry 4:235-246. (Pubitemid 29292173)
20. Tamandani DM, Dahmardeh N, Torkamanzehi A. (2013). Evaluation of hyper-methylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia. Gene 515:163-166.
21. Wong CC, Caspi A, Williams B., Craig IW, Houts R, Ambler A, et al (2010). A longitudinal study of epigenetic variation in twins. Epigenetics 5:516-526.